Despite an efficient and well-tolerated vaccine, hepatitis B (HBV) remains a major public health problem, with more than 250 million people at high risk of developing liver cirrhosis and cancer as a result. HBV treatment ...
Oct 11, 2018
0
1
Millions of people across the globe, including in our own backyard, are living with a viral hepatitis infection and may not even know it. Experts at Baylor College of Medicine say awareness and diagnosis is the first step ...
Jul 31, 2018
0
4
(HealthDay)—A new initiative to increase hepatitis B virus vaccination rates among at-risk adults has been developed, according to a report from the National Foundation for Infectious Diseases (NFID) published in support ...
Jul 30, 2018
0
0
(HealthDay)—Availability of generic antivirals for treating chronic hepatitis B virus (HBV) is increasing, according to research published in the July 20 issue of the U.S. Centers for Disease Control and Prevention's Morbidity ...
Jul 23, 2018
0
1
Hepatitis delta virus (HDV) causes the most aggressive form of viral hepatitis in humans, putting at least 20 million people worldwide at risk of developing liver fibrosis, cirrhosis, and liver cancer. Efforts to develop ...
Jun 27, 2018
0
24
Many European countries lack a comprehensive policy to eliminate viral hepatitis as a major public health threat, according to a patient group-based survey implemented in 25 countries. The Hep-CORE study was coordinated by ...
Apr 18, 2018
0
0
(HealthDay)—Metabolic syndrome (MetS) is prevalent among patients with chronic hepatitis B (HBV) infection, according to a study published online March 29 in Diabetes Care.
Apr 17, 2018
0
5
Multiple adoptive transfers of T cells engineered to carry hepatitis B virus (HBV)-specific T cell receptors (TCRs) has resulted in an objective positive response in a patient with hepatitis B surface antigen (HBsAg)-negative ...
Apr 12, 2018
0
1
Chronic hepatitis B virus (HBV) can progress to cirrhosis and hepatocellular carcinoma (HCC). A study published in The Journal of Molecular Diagnostics describes a new HBV assay that offers advantages over currently used ...
Apr 12, 2018
0
7
Some 300 million people worldwide are living with the deadly hepatitis B virus (HBV), but only one in 20 received adequate treatment, researchers reported Tuesday.
Mar 27, 2018
0
421
